Pfizer's Monthly GLP-1 Push Tests Balance Between Obesity Growth And Dividends [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once monthly injection. The company plans more than 20 anti-obesity trials, including 10 Phase 3 studies targeted for 2026, as it builds out its obesity franchise. This GLP-1 program is aimed at competing with current obesity drug leaders that offer primarily weekly dosing options. For investors following NYSE:PFE, this move into obesity treatments adds a new angle to a business often associated with vaccines and oncology. Obesity care has become a key focus area for large pharmaceutical companies, and dosing convenience can be an important differentiator for both patients and prescribers. The scale of Pfizer's planned trial program indicates that obesity is becoming a central theme in its pipeline, alongside cancer and other therapeutic areas. As more data emerges from PF-08653944 and the broader GLP-1 portfolio, investors can monitor how this effort influen
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Amneal Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Pfizer Declares Second-Quarter 2026 DividendBusiness Wire
- Pfizer Could Surprise Again This Earnings Season (Preview) [Seeking Alpha]Seeking Alpha
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 [Yahoo! Finance]Yahoo! Finance
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026Business Wire
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 4
- 4/10/26 - Form 3
- PFE's page on the SEC website